Geneos Wealth Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-100
| Closed | -$24K | – | 2122 |
|
|
2022
Q3 | $24K | Sell |
100
-500
| -83% | -$120K | ﹤0.01% | 1269 |
|
|
2022
Q2 | $152K | Hold |
600
| – | – | 0.01% | 849 |
|
|
2022
Q1 | $198K | Buy |
600
+100
| +20% | +$33K | 0.01% | 811 |
|
|
2021
Q4 | $179K | Hold |
500
| – | – | 0.01% | 918 |
|
|
2021
Q3 | $161K | Hold |
500
| – | – | 0.01% | 955 |
|
|
2021
Q2 | $158K | Hold |
500
| – | – | 0.01% | 957 |
|
|
2021
Q1 | $160K | Hold |
500
| – | – | ﹤0.01% | 1072 |
|
|
2020
Q4 | $150K | Sell |
500
-10
| -2% | -$3K | 0.01% | 952 |
|
|
2020
Q3 | $135K | Buy |
510
+10
| +2% | +$2.65K | 0.01% | 821 |
|
|
2020
Q2 | $119K | Hold |
500
| – | – | 0.01% | 841 |
|
|
2020
Q1 | $72K | Hold |
500
| – | – | ﹤0.01% | 967 |
|
|
2019
Q4 | $84K | Sell |
500
-100
| -17% | -$16.8K | ﹤0.01% | 1020 |
|
|
2019
Q3 | $105K | Hold |
600
| – | – | 0.01% | 876 |
|
|
2019
Q2 | $156K | Sell |
600
-11
| -2% | -$2.86K | 0.01% | 752 |
|
|
2019
Q1 | $174K | Hold |
611
| – | – | 0.01% | 692 |
|
|
2018
Q4 | $194K | Buy |
611
+11
| +2% | +$3.49K | 0.01% | 613 |
|
|
2018
Q3 | $269K | Hold |
600
| – | – | 0.02% | 542 |
|
|
2018
Q2 | $245K | Hold |
600
| – | – | 0.02% | 517 |
|
|
2018
Q1 | $174K | Hold |
600
| – | – | 0.02% | 575 |
|
|
2017
Q4 | $112K | Buy |
600
+100
| +20% | +$18.7K | 0.01% | 710 |
|
|
2017
Q3 | $84K | Hold |
500
| – | – | 0.01% | 758 |
|
|
2017
Q2 | $71K | Sell |
500
-12
| -2% | -$1.7K | 0.01% | 801 |
|
|
2017
Q1 | $64K | Sell |
512
-10
| -2% | -$1.25K | 0.01% | 806 |
|
|
2016
Q4 | $58K | Buy |
522
+250
| +92% | +$27.8K | 0.01% | 788 |
|
|
2016
Q3 | $34K | Buy |
272
+22
| +9% | +$2.75K | ﹤0.01% | 946 |
|
|
2016
Q2 | $27K | Hold |
250
| – | – | ﹤0.01% | 1026 |
|
|
2016
Q1 | $24K | Buy |
+250
| New | +$24K | ﹤0.01% | 1036 |
|